Aspirin versus low-molecular-weight heparin for ischemic stroke in children: an unanswered question.
deVeber
Gabrielle
G
Chan
Anthony
A
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D002648:Child; D002986:Clinical Trials as Topic / Q000379:methods; D004305:Dose-Response Relationship, Drug; D005240:Feasibility Studies; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D055502:Secondary Prevention; D020521:Stroke / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D016896:Treatment Outcome
D006495:Heparin, Low-Molecular-Weight; D001241:Aspirin